Elion Therapeutics has filed a notice of an exempt offering of securities to raise $83,835,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Elion Therapeutics is raising up to $83,835,000.00 in new funding. Sources indicate that as part of senior management Director, Jim Flynn played a key role…